FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine and concerns a method for determining the presence or level or at least one anti-TNFα drug antibody isotype in a sample, which involves bringing the labelled anti-TNFα drug in contact with a sample to form the labelled complexes between the labelled anti-TNFα drug and each autoantibody isotype; exposing the labelled complexes to ion-exclusion chromatography to separate the labelled complexes; and detecting the labelled complexes. The group of inventions also concerns a method for determining the presence or level of at least one anti-TNFα drug antibody isotype in a sample, which involves bringing the labelled anti-TNFα drug and one or more labelled anti-lg antibodies specific to various antibody isotopes in contact with the sample.
EFFECT: group of inventions provides eliminating the necessity to perform washing procedure to remove low-affinity HACA and HAHA; reducing serum background and noise; reducing a probability of any epitope changes when attached to a solid surface similar to ELISA trays.
30 cl, 9 ex, 31 dwg, 6 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF DETECTING ANTI-TNF PREPARATIONS AND AUTOANTIBODIES | 2010 |
|
RU2571489C2 |
NOVEL METHOD OF DIAGNOSING RHEUMATOID ARTHRITIS AND SET FOR RHEUMATOID ARTHRITIS DIAGNOSTICS | 2011 |
|
RU2554751C2 |
HUMAN ANTIBODIES AND CONJUGATES OF ANTIBODY-PREPARATION AGAINST CD74 | 2012 |
|
RU2636029C2 |
METHOD FOR TREATMENT OF PEDIATRIC DISORDERS/DISEASES | 2018 |
|
RU2778567C2 |
COMPOSITIONS AND METHODS FOR TREATING GAUCHER DISEASE | 2010 |
|
RU2733466C2 |
METHOD TO DIAGNOSE ALLERGIC REACTIONS | 2009 |
|
RU2536291C2 |
Fc-VERSIONS WITH CHANGED BINDING WITH FcRn | 2005 |
|
RU2412200C2 |
POLYPEPTIDE EXPRESSION VECTOR WITH SYALIDASE ACTIVITY, METHOD FOR PROVIDING SYALIDASE ACTIVITY IN CELL CULTURE AND METHOD FOR CONTROLLING PROPERTIES OF Fc-CONTAINING MOLECULES EXPRESSED IN CELL LINE | 2007 |
|
RU2466189C2 |
CD40L ANTAGONIST AND METHODS OF ITS USE | 2019 |
|
RU2812919C2 |
COMPOSITIONS AND METHODS FOR CHARACTERISING MYOPATHY | 2011 |
|
RU2574932C2 |
Authors
Dates
2016-02-10—Published
2011-10-18—Filed